The Clorox Company
CLX
$118.65
-$0.74-0.62%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.10B | 7.02B | 7.17B | 7.47B | 7.09B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.10B | 7.02B | 7.17B | 7.47B | 7.09B |
| Cost of Revenue | 3.90B | 3.86B | 3.98B | 4.14B | 4.03B |
| Gross Profit | 3.21B | 3.16B | 3.19B | 3.33B | 3.07B |
| SG&A Expenses | 1.90B | 1.98B | 2.01B | 2.04B | 1.99B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.00M | -1.00M | 6.00M | 11.00M | 32.00M |
| Total Operating Expenses | 5.91B | 5.96B | 6.12B | 6.32B | 6.17B |
| Operating Income | 1.20B | 1.06B | 1.05B | 1.15B | 922.00M |
| Income Before Tax | 1.08B | 943.00M | 647.00M | 546.00M | 398.00M |
| Income Tax Expenses | 254.00M | 234.00M | 179.00M | 176.00M | 106.00M |
| Earnings from Continuing Operations | 824.00 | 709.00 | 468.00 | 370.00 | 292.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00M | -15.00M | -11.00M | -13.00M | -12.00M |
| Net Income | 810.00M | 694.00M | 457.00M | 357.00M | 280.00M |
| EBIT | 1.20B | 1.06B | 1.05B | 1.15B | 922.00M |
| EBITDA | 1.41B | 1.27B | 1.26B | 1.37B | 1.15B |
| EPS Basic | 6.56 | 5.60 | 3.69 | 2.88 | 2.25 |
| Normalized Basic EPS | 5.54 | 4.84 | 4.80 | 5.25 | 4.09 |
| EPS Diluted | 6.53 | 5.57 | 3.66 | 2.87 | 2.24 |
| Normalized Diluted EPS | 5.51 | 4.81 | 4.77 | 5.23 | 4.08 |
| Average Basic Shares Outstanding | 494.10M | 495.23M | 496.11M | 496.52M | 496.70M |
| Average Diluted Shares Outstanding | 497.15M | 498.46M | 498.64M | 498.60M | 498.57M |
| Dividend Per Share | 4.90 | 4.88 | 4.86 | 4.84 | 4.82 |
| Payout Ratio | 74.32% | 86.60% | 131.07% | 167.23% | 212.50% |